Research ArticleBasic Science Investigations
Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti–Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis
Peter Laverman, Tessa van der Geest, Samantha Y.A. Terry, Danny Gerrits, Birgitte Walgreen, Monique M. Helsen, Tapan K. Nayak, Anne Freimoser-Grundschober, Inja Waldhauer, Ralf J. Hosse, Ekkehard Moessner, Pablo Umana, Christian Klein, Wim J.G. Oyen, Marije I. Koenders and Otto C. Boerman
Journal of Nuclear Medicine May 2015, 56 (5) 778-783; DOI: https://doi.org/10.2967/jnumed.114.152959
Peter Laverman
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Tessa van der Geest
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Samantha Y.A. Terry
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2Department of Imaging Chemistry and Biology, King’s College London, London, United Kingdom
Danny Gerrits
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Birgitte Walgreen
3Department of Experimental Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands
Monique M. Helsen
3Department of Experimental Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands
Tapan K. Nayak
4Roche Pharmaceutical Research and Early Development, Innovation Center Basel, Basel, Switzerland; and
Anne Freimoser-Grundschober
5Roche Pharmaceutical Research and Early Development, Innovation Center Zurich, Schlieren, Switzerland
Inja Waldhauer
5Roche Pharmaceutical Research and Early Development, Innovation Center Zurich, Schlieren, Switzerland
Ralf J. Hosse
5Roche Pharmaceutical Research and Early Development, Innovation Center Zurich, Schlieren, Switzerland
Ekkehard Moessner
5Roche Pharmaceutical Research and Early Development, Innovation Center Zurich, Schlieren, Switzerland
Pablo Umana
5Roche Pharmaceutical Research and Early Development, Innovation Center Zurich, Schlieren, Switzerland
Christian Klein
5Roche Pharmaceutical Research and Early Development, Innovation Center Zurich, Schlieren, Switzerland
Wim J.G. Oyen
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Marije I. Koenders
3Department of Experimental Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands
Otto C. Boerman
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 56, Issue 5
May 1, 2015
Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti–Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis
Peter Laverman, Tessa van der Geest, Samantha Y.A. Terry, Danny Gerrits, Birgitte Walgreen, Monique M. Helsen, Tapan K. Nayak, Anne Freimoser-Grundschober, Inja Waldhauer, Ralf J. Hosse, Ekkehard Moessner, Pablo Umana, Christian Klein, Wim J.G. Oyen, Marije I. Koenders, Otto C. Boerman
Journal of Nuclear Medicine May 2015, 56 (5) 778-783; DOI: 10.2967/jnumed.114.152959
Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti–Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis
Peter Laverman, Tessa van der Geest, Samantha Y.A. Terry, Danny Gerrits, Birgitte Walgreen, Monique M. Helsen, Tapan K. Nayak, Anne Freimoser-Grundschober, Inja Waldhauer, Ralf J. Hosse, Ekkehard Moessner, Pablo Umana, Christian Klein, Wim J.G. Oyen, Marije I. Koenders, Otto C. Boerman
Journal of Nuclear Medicine May 2015, 56 (5) 778-783; DOI: 10.2967/jnumed.114.152959
Jump to section
Related Articles
Cited By...
- Metabolic and molecular imaging in inflammatory arthritis
- FAPI PET/CT: Will It End the Hegemony of 18F-FDG in Oncology?
- Fibroblast Activation Protein-Targeted PET/CT with 68Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18F-FDG PET/CT
- The Latest Developments in Imaging of Fibroblast Activation Protein
- Visualisation of interstitial lung disease by molecular imaging of integrin {alpha}v{beta}3 and somatostatin receptor 2
- FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors
- A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
- Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein Antibody
- Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21
- Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin {alpha}v{beta}3